ImportRefusal LogoImportRefusal

Revi Pharma S.R.L.

Low Risk

FEI: 3010789893 • Milano, Mi • ITALY

FEI

FEI Number

3010789893

📍

Location

Milano, Mi

🇮🇹

Country

ITALY
🏢

Address

Via Filippo Corridoni 11, , Milano, Mi, Italy

Low Risk

FDA Import Risk Assessment

22.3
LowModerateHighCritical

This firm has a minimal history of FDA import refusals with low-severity violations.

Statistics

1
Total Refusals
2
Unique Violations
10/1/2018
Latest Refusal
10/1/2018
Earliest Refusal

Score Breakdown

Violation Severity
45.0×40%
Refusal Volume
11.2×30%
Recency
0.0×20%
Frequency
10.0×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

3361×

INCONSPICU

Information required by the Act to be on the label or labeling does not appear to be conspicuous enough as to render it likely to be read and understood by the ordinary individual under customary conditions of purchase and use.

4831×

DRUG NAME

The article appears to be a drug and fails to bear the proprietary or established name and/or name and quantity of each active ingredient.

Refusal History

DateProductViolationsDivision
10/1/2018
66PCR99ULTRAVIOLET SCREEN/SUNSCREEN N.E.C.
336INCONSPICU
483DRUG NAME
Division of Northeast Imports (DNEI)

Frequently Asked Questions

What is Revi Pharma S.R.L.'s FDA import refusal history?

Revi Pharma S.R.L. (FEI: 3010789893) has 1 FDA import refusal record(s) in our database, spanning from 10/1/2018 to 10/1/2018.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Revi Pharma S.R.L.'s FEI number is 3010789893.

What types of violations has Revi Pharma S.R.L. received?

Revi Pharma S.R.L. has been cited for 2 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about Revi Pharma S.R.L. come from?

All FDA import refusal data for Revi Pharma S.R.L. is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.